Literature DB >> 33517302

Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy.

Floriane Jochum1, Gabrielle Aubry2, Madeleine Pellerin3, Camille Billard3, Emilie Faller3, Thomas Boisrame3, Lise Lecointre3,4,5, Cherif Akladios3.   

Abstract

BACKGROUND/AIM: This study aimed to evaluate the relevance of laparoscopy in comparison with laparotomy in the management of ovarian cancer in well-selected patients. PATIENTS AND METHODS: Data of consecutive ovarian cancer patients treated by laparoscopy were matched 1:1 to a cohort of patients operated by laparotomy using a propensity score matching. The inclusion criteria included patients who underwent a complete staging procedure in the early stages and optimal upfront or interval debulking surgery for advanced ovarian cancer.
RESULTS: In total, 153 patients were included. Propensity score matching led to the analysis of 41 well-balanced pairs of patients. For a median follow-up of 34.0 [19.0-64.0] months and 38.0 [24.5-75.0] months, respectively, no difference was found between the two groups in regards to overall survival (p=0.28) and disease-free survival (p=0.89).
CONCLUSION: In well-selected patients, laparoscopic surgery may be a safe and effective alternative to laparotomy.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ovarian cancer; laparoscopy; minimally invasive surgery

Year:  2021        PMID: 33517302     DOI: 10.21873/anticanres.14849

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Clinical Availability of Tumour Biopsy Using Diagnostic Laparoscopy for Advanced Ovarian Cancer.

Authors:  Suguru Odajima; Kazu Ueda; Satoshi Hosoya; Keisuke Tomita; Sayako Kato; Yuichi Shoburu; Ayako Kawabata; Yasushi Iida; Nozomu Yanaihara; Aikou Okamoto
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.